Literature DB >> 21297119

Isolation, functional, and partial biochemical characterization of galatrox, an acidic lectin from Bothrops atrox snake venom.

Elaine de Paula Mendonça-Franqueiro1, Raquel de Melo Alves-Paiva, Marco Aurélio Sartim, Daniel Roberto Callejon, Helder Henrique Paiva, Gilmara Ausech Antonucci, José César Rosa, Adélia Cristina Oliveira Cintra, João José Franco, Eliane Candiani Arantes, Marcelo Dias-Baruffi, Suely Vilela Sampaio.   

Abstract

Snake venom lectins have been studied in regard to their chemical structure and biological functions. However, little is known about lectins isolated from Bothrops atrox snake venom. We report here the isolation and partial functional and biochemical characterization of an acidic glycan-binding protein called galatrox from this venom. This lectin was purified by affinity chromatography using a lactosyl-sepharose column, and its homogeneity and molecular mass were evaluated by high-performance liquid chromatography, sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry. The purified galatrox was homogeneous and characterized as an acidic protein (pI 5.2) with a monomeric and dimeric molecular mass of 16.2 and 32.5 kDa, respectively. Alignment of N-terminal and internal amino acid sequences of galatrox indicated that this protein exhibits high homology to other C-type snake venom lectins. Galatrox showed optimal hemagglutinating activity at a concentration of 100 μg/ml and this effect was drastically inhibited by lactose, ethylenediaminetetraacetic acid, and heating, which confirmed galatrox's lectin activity. While galatrox failed to induce the same level of paw edema or mast cell degranulation as B. atrox crude venom, galatrox did alter cellular viability, which suggested that galatrox might contribute to venom toxicity by directly inducing cell death.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21297119     DOI: 10.1093/abbs/gmr003

Source DB:  PubMed          Journal:  Acta Biochim Biophys Sin (Shanghai)        ISSN: 1672-9145            Impact factor:   3.848


  5 in total

Review 1.  Pharmaceutical and biomedical applications of affinity chromatography: recent trends and developments.

Authors:  David S Hage; Jeanethe A Anguizola; Cong Bi; Rong Li; Ryan Matsuda; Efthimia Papastavros; Erika Pfaunmiller; John Vargas; Xiwei Zheng
Journal:  J Pharm Biomed Anal       Date:  2012-01-14       Impact factor: 3.935

2.  Sacha inchi seeds from sub-tropical cultivation: effects of roasting on antinutrients, antioxidant capacity and oxidative stability.

Authors:  Larissa Braga Bueno-Borges; Marco Aurélio Sartim; Claudia Carreño Gil; Suely Vilela Sampaio; Paulo Hercílio Viegas Rodrigues; Marisa Aparecida Bismara Regitano-d'Arce
Journal:  J Food Sci Technol       Date:  2018-07-23       Impact factor: 2.701

3.  Galatrox is a C-type lectin in Bothrops atrox snake venom that selectively binds LacNAc-terminated glycans and can induce acute inflammation.

Authors:  Marco A Sartim; Thalita B Riul; Camillo Del Cistia-Andrade; Sean R Stowell; Connie M Arthur; Carlos A Sorgi; Lucia H Faccioli; Richard D Cummings; Marcelo Dias-Baruffi; Suely V Sampaio
Journal:  Glycobiology       Date:  2014-06-27       Impact factor: 4.313

4.  Bothrops atrox, the most important snake involved in human envenomings in the amazon: How venomics contributes to the knowledge of snake biology and clinical toxinology.

Authors:  Wuelton Marcelo Monteiro; Jorge Carlos Contreras-Bernal; Pedro Ferreira Bisneto; Jacqueline Sachett; Iran Mendonça da Silva; Marcus Lacerda; Allyson Guimarães da Costa; Fernando Val; Lisele Brasileiro; Marco Aurélio Sartim; Sâmella Silva-de-Oliveira; Paulo Sérgio Bernarde; Igor L Kaefer; Felipe Gobbi Grazziotin; Fan Hui Wen; Ana Maria Moura-da-Silva
Journal:  Toxicon X       Date:  2020-04-23

5.  Snake venom galactoside-binding lectins: a structural and functional overview.

Authors:  Marco A Sartim; Suely V Sampaio
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2015-09-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.